MedPath

A randomized trial of propofol versus midazolam of sedation during radio frequency ablation in patients with hepatocellular carcinoma

Not Applicable
Conditions
Hepatocellular carcinoma
Registration Number
JPRN-UMIN000011443
Lead Sponsor
Chiba university hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
140
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients with sever cardiovascular disorder 2)American Society of Anesthesiologists (ASA) : 4 or more 3)Body Mass Index (BMI): 30 or more 4)Patients who knwn cotraindications for propfol pr midazolam

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
patient's degree of satisfaction
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath